コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 with biocompatible ceramic nanoparticles of tricalcium phosphate.
2 the formation of second phases such as beta-tricalcium phosphate.
3 ed at the Ca(2) and/or the Ca(3) position of tricalcium phosphate, a known component of HAP grain bou
4 a-tricalcium phosphate (beta-TCP), and alpha-tricalcium phosphate (alpha-TCP) phases, with compositio
6 ramic bone substitute (SBC) composed of beta-tricalcium phosphate and hydroxyapatite after different
7 of novel etchant pastes developed with beta-tricalcium phosphate and monocalcium phosphate monohydra
8 platelet-derived growth factor-BB plus beta-tricalcium phosphate) are generally comparable with demi
9 neous BMMSC transplants using hydroxyapatite tricalcium phosphate as a carrier suppressed age-related
10 efect by using an interconnected porous beta-tricalcium phosphate (B-TCP) scaffold with multiple chan
11 ), with blood-clot in the alveolus; BG, beta-tricalcium phosphate-based biomaterial; DG, 10% doxycycl
12 (DIPY-3DPBC) scaffolds composed of 100% beta-tricalcium phosphate (beta -TCP) in an immature rabbit m
13 ation and specification of calcium in a beta-tricalcium phosphate (beta-Ca3(PO4)2 scaffold implanted
14 ) to compare the safety and efficacy of beta-tricalcium phosphate (beta-TCP) + 0.3 mg/ml recombinant
15 quantify doxycycline (DOX) release from beta-tricalcium phosphate (beta-TCP) after EDTA root surface
16 The aim of these studies was to treat beta-tricalcium phosphate (beta-TCP) and calcium sulfate (CaS
17 ollowing augmentation with allograft or beta-tricalcium phosphate (beta-TCP) and evaluate orthodontic
18 ve treatment of intrabony defects using beta tricalcium phosphate (beta-TCP) as a bone regeneration m
19 rived growth factor-BB (rhPDGF-BB) with beta-tricalcium phosphate (beta-TCP) compared to beta-TCP plu
20 ctor (rhPDGF-BB) mixed with a synthetic beta-tricalcium phosphate (beta-TCP) matrix for the treatment
22 ir powder abrasive (APA) treatment with beta-tricalcium phosphate (beta-TCP) powder, using various po
23 h factor 2 (FGF-2) when combined with a beta-tricalcium phosphate (beta-TCP) scaffold carrier placed
24 he potential of micrograft particles of beta-tricalcium phosphate (beta-TCP) to enhance the binding a
25 nalyses confirmed hydroxyapatite (HAp), beta-tricalcium phosphate (beta-TCP), and alpha-tricalcium ph
26 sociated with bone substitute materials beta-tricalcium phosphate (beta-TCP), biphasic calcium phosph
27 n conjunction with one of the carriers: beta-tricalcium phosphate (beta-TCP), biphasic calcium phosph
31 se response of rhGDF-5 lyophilized onto beta-tricalcium phosphate (bTCP) granules for periodontal tis
32 gated the efficacy of a biphasic synthetic B-tricalcium phosphate/calcium sulfate (B-TCP/CS) bone gra
33 lubility were used: calcium carbonate (CaC), tricalcium phosphate (CaP) and calcium gluconate (CaG).
34 ly within vehicles containing hydroxyapatite/tricalcium phosphate ceramics (HA/TCP) in the form of bl
35 the chewing of a 2.5% (mass fraction) alpha-tricalcium-phosphate-fortified (alpha-TCP) experimental
36 es potential of a 2.5% (mass fraction) alpha-tricalcium-phosphate-fortified experimental gum by measu
37 into: Group 1- 5% NaF, Group 2- 5% NaF with tricalcium phosphate, Group 3- 5% NaF with casein phosph
38 as to determine the effect of hydroxyapatite tricalcium phosphate (HA-TCP) on osseous repair in the r
39 D) associated with a hydroxyapatite and beta-tricalcium phosphate (HA/beta-TCP) implant to EMD alone
40 In six mini-pigs, synthetic hydroxyapatite/tricalcium phosphate (HA/TCP) particles were inserted in
42 MMSC; bone sialoprotein, BSP; hydroxyapatite/tricalcium phosphate, HA/TCP; Hertwig's epithelial root
43 were implanted with rhBMP-2 (0.4 mg/mL) in a tricalcium phosphate/hydroxyapatite/ absorbable collagen
44 al furcation defects were randomized to beta-tricalcium-phosphate/hydroxyapatite graft (BONE group),
45 esenchymal stem cell; HA/TCP, hydroxyapatite/tricalcium phosphate; OMSC, orofacial mesenchymal stem c
48 graft, Poly Lactic-Co-Glycolic Acid-Coated B-Tricalcium Phosphate (PLGA-B-TCP), for ARP purposes [Gro
49 ft, Poly Lactic-Co-Glycolic Acid-Coated beta-Tricalcium Phosphate (PLGA-beta-TCP), for ARP purposes [
50 y investigated the local application of beta-tricalcium phosphate scaffold matrix with or without two
51 three-dimensional printed (3DP) SiO(2)-doped tricalcium phosphate (TCP) scaffold functionalized with
52 uction with demineralized bone powder (DBP), tricalcium phosphate (TCP), or non-grafted controls.
53 man platelet-derived growth factor-BB + beta-tricalcium phosphate (test), both in combination with a
54 (~ 850 um), made by hydroxyapatite and beta-tricalcium phosphate to accommodate the bony parts under
55 rived growth factor-BB (rhPDGF-BB) with beta-tricalcium phosphate were shown to be efficacious in reg